-
Mashup Score: 3
PURPOSE Early-onset colorectal cancer (EOCRC), defined as CRC diagnosed before age 50 years, has increased significantly worldwide. The majority of EOCRCs do not appear to be driven by genetic factors and may be influenced by environmental factors. We hypothesized that sociodemographic disparities exist in EOCRC. The purpose was of the study was to examine the geographic disparities in patients with EOCRC. METHODS We retrospectively examined the SEER database from 1976 to 2016 to examine the geographic disparities in EOCRC. A total of 73,378 patients with EOCRC were included in the analysis. We performed univariate and multivariable analyses to evaluate overall survival (OS) and disease-specific survival (DSS). Sociodemographic factors, including the location of residence (metropolitan areas [MA] or rural areas [RA]), sex, race, insurance status, and marital status, were included in the statistical analysis. RESULTS The incidence and mortality rates were consistently higher in RA versu
Source: ascopubs.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18Oral Carbon Monoxide Enhances Autophagy Modulation in Prostate, Pancreatic, and Lung Cancers - 11 month(s) ago
Advanced Science is a high-impact, interdisciplinary science journal covering materials science, physics, chemistry, medical and life sciences, and engineering.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Summary. A recent article analyzed paired cell-free DNA among patients with platinum-sensitive BRCA- or PALB2-mutated pancreatic cancer who received maintenance olaparib. Reversion mutations were linked with worse outcomes. These types of paired correlative studies are needed to improve our understanding of drug resistance and guide future clinical trials.See related article by Brown et al., p. xxxx
Source: aacrjournals.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10Program Guide – ASCO Meeting Program Guide - 1 year(s) ago
Erin Bange, Kerry Coughlin, Wenrui Li, Timothy Brown, Daniel Ragusano, Eesha Balar, Dhivya Arasappan, Michelle Nnaji, Elliot Kim, Corey Alban, Sindhuja Uppuluri, Lindsey Zinck, Donna Capozzi, Michael Josephs, Danielle Zubka, Roy Rosin, Mohan Balachandran, Lawrence Shulman, Carmen Guerra, Ronac Mamtani Memorial Sloan Kettering Cancer Center, Penn Abramson Cancer Center, University of Pennsylvania, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Perelman School of Medicine, University
Source: meetings.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
29 Followers, 21 Following, 2 Posts – See Instagram photos and videos from UTSW Heme/Onc Fellowship (@utsw_hemeoncfellows)
Source: www.instagram.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Listen to this episode from Plenary Session on Spotify. Simultaneously released on Sensible Medicine. Time to subscribe to Sensible Medicine substack and podcast.
Source: open.spotify.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 38Oliver Anthony Reaches #1 Spot On U.S. iTunes Chart With Powerful Blue Collar Anthem “Rich Men North Of Richmond” - 1 year(s) ago
A RIFF on what country is really about.
Source: www.whiskeyriff.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 93Homepage of Mark Cuban Cost Plus Drugs - 2 year(s) ago
Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.
Source: costplusdrugs.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Nonsteroidal anti-inflammatory drugs as a targeted therapy for bone marrow failure in Ghosal hematodiaphyseal dysplasia - 2 year(s) ago
Key Points. NSAIDs can normalize hematologic parameters and serum inflammatory markers in patients with Ghosal hematodiaphyseal dysplasia syndrome.Prostaglandin
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Blocking COX unlocks response in GHDD - 2 year(s) ago
In this issue of Blood, Brown et al show that novel therapy with intermediate- to high-dose nonsteroidal antiinflammatory drugs (NSAIDs) overcomes augmented inf
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
Great new paper from @Deebacca and @Sarbaji85064063 in @JCOOP_ASCO examining disparities in early onset CRC within the SEER database. https://t.co/Rh1v1bRgPZ